ERYTHROPOIESIS AND IRON METABOLISM IN AMEMIC CANCER SURGICAL PATIENTS AFTER THERAPY WITH RECOMBINANT HUMAN ERYTHROPOIETIN: A DOSE-RESPONSE STUDY | Publicación